Smithsonian Magazine on MSN
Scientists engineered cancer-fighting cells inside patients' bodies—and two early trials show promise
CAR T-cell therapy can be a lifesaving treatment for blood cancers like leukemia and lymphoma. The gene therapy trains a patient’s T cells—white blood cells that play an important role in the immune ...
Kelonia Therapeutics' KLN-1010 has shown promising early results in a phase 1 trial for relapsed or refractory multiple ...
ROTTERDAM, the Netherlands, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Pan Cancer T B.V., a biotech company pioneering next-generation ...
At this year's ASH congress, the results of the phase 1b/2 DURGA-1 of AZD0120 – a dual BCMA and CD19-directed CAR-T therapy – ...
As Chief Editor of one of the two journals in which Biopharma Dealmakers appears, I have a keen interest in the process of translating biomedical research into new drugs, including the partnerships ...
While 2025 has not been a banner year for biopharma dealmaking, antibodies that bind two or more molecular targets—so-called multispecifics—have taken center stage. The top three licensing deals and ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback